img

Global Duck Virus Enteritis Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Duck Virus Enteritis Vaccine Market Research Report 2024

Vaccine for Duck Virus Enteritis, A duck enteritis virus- vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks.
According to Mr Accuracy reports new survey, global Duck Virus Enteritis Vaccine market is projected to reach US$ 97.9 million in 2029, increasing from US$ 67 million in 2022, with the CAGR of 5.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Duck Virus Enteritis Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Duck Virus Enteritis Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Ceva Santé Animale
Chengdu TECBOND Biological
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
International Duck Research Cooperative
MSD Animal Health (Merck)
Ringpu (Tianjin)Bio-Pharmacy
Veterinary Research Institute
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Duck
Others

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Duck Virus Enteritis Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Duck Virus Enteritis Vaccine Market Overview
1.1 Product Overview and Scope of Duck Virus Enteritis Vaccine
1.2 Duck Virus Enteritis Vaccine Segment by Type
1.2.1 Global Duck Virus Enteritis Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Duck Virus Enteritis Vaccine Segment by Application
1.3.1 Global Duck Virus Enteritis Vaccine Market Value by Application: (2024-2034)
1.3.2 Duck
1.3.3 Others
1.4 Global Duck Virus Enteritis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Duck Virus Enteritis Vaccine Revenue 2018-2029
1.4.2 Global Duck Virus Enteritis Vaccine Sales 2018-2029
1.4.3 Global Duck Virus Enteritis Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Duck Virus Enteritis Vaccine Market Competition by Manufacturers
2.1 Global Duck Virus Enteritis Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Duck Virus Enteritis Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Duck Virus Enteritis Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Duck Virus Enteritis Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Duck Virus Enteritis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Duck Virus Enteritis Vaccine, Product Type & Application
2.7 Duck Virus Enteritis Vaccine Market Competitive Situation and Trends
2.7.1 Duck Virus Enteritis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Duck Virus Enteritis Vaccine Players Market Share by Revenue
2.7.3 Global Duck Virus Enteritis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Duck Virus Enteritis Vaccine Retrospective Market Scenario by Region
3.1 Global Duck Virus Enteritis Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Duck Virus Enteritis Vaccine Global Duck Virus Enteritis Vaccine Sales by Region: 2018-2029
3.2.1 Global Duck Virus Enteritis Vaccine Sales by Region: 2018-2024
3.2.2 Global Duck Virus Enteritis Vaccine Sales by Region: 2024-2029
3.3 Global Duck Virus Enteritis Vaccine Global Duck Virus Enteritis Vaccine Revenue by Region: 2018-2029
3.3.1 Global Duck Virus Enteritis Vaccine Revenue by Region: 2018-2024
3.3.2 Global Duck Virus Enteritis Vaccine Revenue by Region: 2024-2029
3.4 North America Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.4.1 North America Duck Virus Enteritis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Duck Virus Enteritis Vaccine Sales by Country (2018-2029)
3.4.3 North America Duck Virus Enteritis Vaccine Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.5.1 Europe Duck Virus Enteritis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Duck Virus Enteritis Vaccine Sales by Country (2018-2029)
3.5.3 Europe Duck Virus Enteritis Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Duck Virus Enteritis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Duck Virus Enteritis Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Duck Virus Enteritis Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Duck Virus Enteritis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Duck Virus Enteritis Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Duck Virus Enteritis Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Duck Virus Enteritis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Duck Virus Enteritis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Duck Virus Enteritis Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Duck Virus Enteritis Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Duck Virus Enteritis Vaccine Sales by Type (2018-2029)
4.1.1 Global Duck Virus Enteritis Vaccine Sales by Type (2018-2024)
4.1.2 Global Duck Virus Enteritis Vaccine Sales by Type (2024-2029)
4.1.3 Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Duck Virus Enteritis Vaccine Revenue by Type (2018-2029)
4.2.1 Global Duck Virus Enteritis Vaccine Revenue by Type (2018-2024)
4.2.2 Global Duck Virus Enteritis Vaccine Revenue by Type (2024-2029)
4.2.3 Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Duck Virus Enteritis Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Duck Virus Enteritis Vaccine Sales by Application (2018-2029)
5.1.1 Global Duck Virus Enteritis Vaccine Sales by Application (2018-2024)
5.1.2 Global Duck Virus Enteritis Vaccine Sales by Application (2024-2029)
5.1.3 Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Duck Virus Enteritis Vaccine Revenue by Application (2018-2029)
5.2.1 Global Duck Virus Enteritis Vaccine Revenue by Application (2018-2024)
5.2.2 Global Duck Virus Enteritis Vaccine Revenue by Application (2024-2029)
5.2.3 Global Duck Virus Enteritis Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Duck Virus Enteritis Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ceva Santé Animale
6.1.1 Ceva Santé Animale Corporation Information
6.1.2 Ceva Santé Animale Description and Business Overview
6.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Portfolio
6.1.5 Ceva Santé Animale Recent Developments/Updates
6.2 Chengdu TECBOND Biological
6.2.1 Chengdu TECBOND Biological Corporation Information
6.2.2 Chengdu TECBOND Biological Description and Business Overview
6.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Portfolio
6.2.5 Chengdu TECBOND Biological Recent Developments/Updates
6.3 Institute of Animal Health and Veterinary Biologicals
6.3.1 Institute of Animal Health and Veterinary Biologicals Corporation Information
6.3.2 Institute of Animal Health and Veterinary Biologicals Description and Business Overview
6.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Portfolio
6.3.5 Institute of Animal Health and Veterinary Biologicals Recent Developments/Updates
6.4 Institute of Veterinary Preventive Medicine
6.4.1 Institute of Veterinary Preventive Medicine Corporation Information
6.4.2 Institute of Veterinary Preventive Medicine Description and Business Overview
6.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Portfolio
6.4.5 Institute of Veterinary Preventive Medicine Recent Developments/Updates
6.5 International Duck Research Cooperative
6.5.1 International Duck Research Cooperative Corporation Information
6.5.2 International Duck Research Cooperative Description and Business Overview
6.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Portfolio
6.5.5 International Duck Research Cooperative Recent Developments/Updates
6.6 MSD Animal Health (Merck)
6.6.1 MSD Animal Health (Merck) Corporation Information
6.6.2 MSD Animal Health (Merck) Description and Business Overview
6.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Portfolio
6.6.5 MSD Animal Health (Merck) Recent Developments/Updates
6.7 Ringpu (Tianjin)Bio-Pharmacy
6.6.1 Ringpu (Tianjin)Bio-Pharmacy Corporation Information
6.6.2 Ringpu (Tianjin)Bio-Pharmacy Description and Business Overview
6.6.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Portfolio
6.7.5 Ringpu (Tianjin)Bio-Pharmacy Recent Developments/Updates
6.8 Veterinary Research Institute
6.8.1 Veterinary Research Institute Corporation Information
6.8.2 Veterinary Research Institute Description and Business Overview
6.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Portfolio
6.8.5 Veterinary Research Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Duck Virus Enteritis Vaccine Industry Chain Analysis
7.2 Duck Virus Enteritis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Duck Virus Enteritis Vaccine Production Mode & Process
7.4 Duck Virus Enteritis Vaccine Sales and Marketing
7.4.1 Duck Virus Enteritis Vaccine Sales Channels
7.4.2 Duck Virus Enteritis Vaccine Distributors
7.5 Duck Virus Enteritis Vaccine Customers
8 Duck Virus Enteritis Vaccine Market Dynamics
8.1 Duck Virus Enteritis Vaccine Industry Trends
8.2 Duck Virus Enteritis Vaccine Market Drivers
8.3 Duck Virus Enteritis Vaccine Market Challenges
8.4 Duck Virus Enteritis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Duck Virus Enteritis Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Duck Virus Enteritis Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Duck Virus Enteritis Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Duck Virus Enteritis Vaccine Sales (M Units) of Key Manufacturers (2018-2024)
Table 5. Global Duck Virus Enteritis Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Duck Virus Enteritis Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Duck Virus Enteritis Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Duck Virus Enteritis Vaccine Average Price (USD/K Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Duck Virus Enteritis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Duck Virus Enteritis Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Duck Virus Enteritis Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Duck Virus Enteritis Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Duck Virus Enteritis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duck Virus Enteritis Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Duck Virus Enteritis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Duck Virus Enteritis Vaccine Sales by Region (2018-2024) & (M Units)
Table 18. Global Duck Virus Enteritis Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Duck Virus Enteritis Vaccine Sales by Region (2024-2029) & (M Units)
Table 20. Global Duck Virus Enteritis Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Duck Virus Enteritis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Duck Virus Enteritis Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Duck Virus Enteritis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Duck Virus Enteritis Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Duck Virus Enteritis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (M Units)
Table 27. North America Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (M Units)
Table 28. North America Duck Virus Enteritis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Duck Virus Enteritis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Duck Virus Enteritis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (M Units)
Table 32. Europe Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (M Units)
Table 33. Europe Duck Virus Enteritis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Duck Virus Enteritis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Duck Virus Enteritis Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Duck Virus Enteritis Vaccine Sales by Region (2018-2024) & (M Units)
Table 37. Asia Pacific Duck Virus Enteritis Vaccine Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Duck Virus Enteritis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Duck Virus Enteritis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Duck Virus Enteritis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (M Units)
Table 42. Latin America Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Duck Virus Enteritis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Duck Virus Enteritis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Country (2018-2024) & (M Units)
Table 47. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Duck Virus Enteritis Vaccine Sales (M Units) by Type (2018-2024)
Table 51. Global Duck Virus Enteritis Vaccine Sales (M Units) by Type (2024-2029)
Table 52. Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Duck Virus Enteritis Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Duck Virus Enteritis Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Duck Virus Enteritis Vaccine Price (USD/K Unit) by Type (2018-2024)
Table 59. Global Duck Virus Enteritis Vaccine Price (USD/K Unit) by Type (2024-2029)
Table 60. Global Duck Virus Enteritis Vaccine Sales (M Units) by Application (2018-2024)
Table 61. Global Duck Virus Enteritis Vaccine Sales (M Units) by Application (2024-2029)
Table 62. Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Duck Virus Enteritis Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Duck Virus Enteritis Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Duck Virus Enteritis Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Duck Virus Enteritis Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Duck Virus Enteritis Vaccine Price (USD/K Unit) by Application (2018-2024)
Table 69. Global Duck Virus Enteritis Vaccine Price (USD/K Unit) by Application (2024-2029)
Table 70. Ceva Santé Animale Corporation Information
Table 71. Ceva Santé Animale Description and Business Overview
Table 72. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 73. Ceva Santé Animale Duck Virus Enteritis Vaccine Product
Table 74. Ceva Santé Animale Recent Developments/Updates
Table 75. Chengdu TECBOND Biological Corporation Information
Table 76. Chengdu TECBOND Biological Description and Business Overview
Table 77. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 78. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product
Table 79. Chengdu TECBOND Biological Recent Developments/Updates
Table 80. Institute of Animal Health and Veterinary Biologicals Corporation Information
Table 81. Institute of Animal Health and Veterinary Biologicals Description and Business Overview
Table 82. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 83. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product
Table 84. Institute of Animal Health and Veterinary Biologicals Recent Developments/Updates
Table 85. Institute of Veterinary Preventive Medicine Corporation Information
Table 86. Institute of Veterinary Preventive Medicine Description and Business Overview
Table 87. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 88. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product
Table 89. Institute of Veterinary Preventive Medicine Recent Developments/Updates
Table 90. International Duck Research Cooperative Corporation Information
Table 91. International Duck Research Cooperative Description and Business Overview
Table 92. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 93. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product
Table 94. International Duck Research Cooperative Recent Developments/Updates
Table 95. MSD Animal Health (Merck) Corporation Information
Table 96. MSD Animal Health (Merck) Description and Business Overview
Table 97. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 98. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product
Table 99. MSD Animal Health (Merck) Recent Developments/Updates
Table 100. Ringpu (Tianjin)Bio-Pharmacy Corporation Information
Table 101. Ringpu (Tianjin)Bio-Pharmacy Description and Business Overview
Table 102. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 103. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product
Table 104. Ringpu (Tianjin)Bio-Pharmacy Recent Developments/Updates
Table 105. Veterinary Research Institute Corporation Information
Table 106. Veterinary Research Institute Description and Business Overview
Table 107. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 108. Veterinary Research Institute Duck Virus Enteritis Vaccine Product
Table 109. Veterinary Research Institute Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Duck Virus Enteritis Vaccine Distributors List
Table 113. Duck Virus Enteritis Vaccine Customers List
Table 114. Duck Virus Enteritis Vaccine Market Trends
Table 115. Duck Virus Enteritis Vaccine Market Drivers
Table 116. Duck Virus Enteritis Vaccine Market Challenges
Table 117. Duck Virus Enteritis Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Duck Virus Enteritis Vaccine
Figure 2. Global Duck Virus Enteritis Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Duck Virus Enteritis Vaccine Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Duck Virus Enteritis Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Duck Virus Enteritis Vaccine Market Share by Application in 2022 & 2029
Figure 8. Duck
Figure 9. Others
Figure 10. Global Duck Virus Enteritis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Duck Virus Enteritis Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Duck Virus Enteritis Vaccine Sales (2018-2029) & (M Units)
Figure 13. Global Duck Virus Enteritis Vaccine Average Price (USD/K Unit) & (2018-2029)
Figure 14. Duck Virus Enteritis Vaccine Report Years Considered
Figure 15. Duck Virus Enteritis Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Duck Virus Enteritis Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Duck Virus Enteritis Vaccine Players: Market Share by Revenue in 2022
Figure 18. Duck Virus Enteritis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Duck Virus Enteritis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Duck Virus Enteritis Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Duck Virus Enteritis Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. the United States Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Duck Virus Enteritis Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Duck Virus Enteritis Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Duck Virus Enteritis Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Duck Virus Enteritis Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Duck Virus Enteritis Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Duck Virus Enteritis Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Duck Virus Enteritis Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Duck Virus Enteritis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Duck Virus Enteritis Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Duck Virus Enteritis Vaccine by Type (2018-2029)
Figure 54. Global Duck Virus Enteritis Vaccine Price (USD/K Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Duck Virus Enteritis Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Duck Virus Enteritis Vaccine by Application (2018-2029)
Figure 57. Global Duck Virus Enteritis Vaccine Price (USD/K Unit) by Application (2018-2029)
Figure 58. Duck Virus Enteritis Vaccine Value Chain
Figure 59. Duck Virus Enteritis Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed